Skip to main content

Table 5 Patient cutaneous and systemic adverse events

From: Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia

Patient

Cutaneous adverse events

Systemic adverse events

1

Grade 1 erythema; grade 2 skin ulceration

None

2

Grade 2 skin ulceration

Grade 1 anemia

3

Grade 1 skin ulceration

None

4

Grade 2 skin ulceration

Grade 2 ALT elevation; Grade 1 CK elevation

5

Grade 2 skin ulceration

Grade 1 anemia

6

Grade 1 edema and swelling

None

7

Grade 1 erythema and grade 1 tumor necrosis

Grade 1 nausea; Grade 1 lethargy